牛心包补片重建下腔静脉用于肾细胞癌切除的并发症与结局
该回顾性队列分析评估了15例肾细胞癌患者行下腔静脉切除后使用牛心包补片或管状间置移植物重建的术后并发症与总生存。结果显示3例出现Clavien-Dindo≥3级短期并发症,2例发生移植物相关长期血栓,中位总生存46.5个月(95%CI 36.9-56.1),无围手术期死亡。作者认为在经验丰富的中心,牛心包重建下腔静脉是安全的。
要点
- 牛心包可用于肾癌合并下腔静脉瘤栓的补片或管状重建。
- 短期严重并发症(Clavien-Dindo≥3级)发生3例,无围手术期死亡。
- 中位总生存46.5个月,长期死亡均因疾病进展。
核心结论
- 在经验丰富的中心,使用牛心包移植物重建下腔静脉是安全的,可考虑作为首选材料。
研究设计与样本
- 回顾性队列分析,纳入2010至2018年连续15例因肾细胞癌行下腔静脉切除并牛心包重建的患者。
主要发现
- 9例采用管状间置移植物,6例采用补片修复。
- 3例发生Clavien-Dindo 3级或以上短期并发症。
- 管状间置与补片修复的综合并发症指数无差异。
- 2例发生需临时抗凝的长期移植物相关血栓。
- 中位总生存46.5个月(95%CI 36.9-56.1),无围手术期死亡,长期死亡均因疾病进展。
关键数值与推荐
- 管状间置移植物9例,补片修复6例。
- Clavien-Dindo≥3级短期并发症3例。
- 移植物相关长期血栓2例。
- 总生存46.5个月(95%CI 36.9-56.1)。
临床怎么用
- 对于需行下腔静脉切除重建的肾细胞癌患者,牛心包是安全可选的移植物材料。
- 牛心包移植物通畅性好,无需常规长期抗凝。
局限性
- 回顾性设计,样本量仅15例。
- 单中心经验,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the postoperative complication rate and overall survival when bovine pericardium is used as graft material for inferior vena cava (IVC) reconstructions in patients with renal cell carcinoma (RCC). The ideal graft material is yet to be established, with synthetic grafts widely studied and used in the current literature. METHODS: We performed a retrospective cohort analysis of consecutive patients who underwent IVC reconstructions as part of resection for RCC, using bovine pericardium as either a patch repair or tubular interposition graft. RESULTS: A total of 15 patients underwent resection with IVC reconstruction between 2010 and 2018. Nine patients had tubular interposition grafts and 6 had patch repairs. Three patients had Clavien-Dindo grade 3 or higher short-term complications. There was no difference in Comprehensive Complications Index between those who had interposition grafts and patch repairs. Two patients had a long-term graft-associated thrombus requiring temporary anticoagulation. Overall survival was 46.5 months (95% confidence interval [CI] 36.9-56.1). There were no perioperative deaths. All long-term deaths were due to disease progression. CONCLUSION: Reconstruction of the IVC with a bovine pericardium graft is safe in experienced centers. Bovine pericardium could be considered as the material of choice, given its safety in the immediate postoperative period, ease of use, and patency without routine long-term anticoagulation. Advanced surgical management leads to good overall survival in this cohort with high tumor burden.
引用
- Morris PD, Furtado R, Pulitano C, et al. Inferior Vena Cava Resection and Reconstruction with Bovine Pericardium for Renal Cell Carcinoma: Complications and Outcomes. Urology. 2019. PMID: 31542462. doi:10.1016/j.urology.2019.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。